Following non-submission
AWMSG advice |
||
| Status: Not endorsed (Statement of Advice) | ||
In the absence of a submission from the holder of the marketing authorisation, bimatoprost/timolol (Ganfort®) eye drops, in single-dose container cannot be endorsed for use within NHS Wales for the reduction of intraocular pressure in adult patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues. |
||
|
||
Medicine details |
||
| Medicine name | bimatoprost/timolol (Ganfort®) | |
| Formulation | single-dose container 0.3 mg/ml/5 mg/ml eye drops | |
| Reference number | 2370 | |
| Indication | For the reduction of intraocular pressure in adult patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues. |
|
| Company | Allergan Ltd | |
| BNF chapter | Eye | |
| Submission type | Non-submission | |
| Status | Not endorsed (Statement of Advice) | |
| Date of issue | 27/02/2014 | |